Open access
Open access
Powered by Google Translator Translator

Oncology (all articles)

[Abstract Only] Randomized Trial: Similar Survival Outcomes After Laparoscopy-assisted Distal Gastrectomy vs. Open Distal Gastrectomy for Clinical Stage I Gastric Cancer

26 Nov, 2019 | 07:59h | UTC

Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)

 

Related Commentary on Twitter

 

Review: Immune Checkpoint Inhibitor-associated Gastrointestinal and Hepatic Adverse Events and Their Management

26 Nov, 2019 | 07:34h | UTC

Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management – Therapeutic Advances in Gastroenterology (free)

Related: Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor – Portuguese Journal of Gastroenterology (free) AND Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)

 

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer

24 Nov, 2019 | 20:43h | UTC

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort – European Urology (free)

 

Consensus Recommendations: Management of Adults and Children Undergoing CAR T-Cell Therapy

24 Nov, 2019 | 20:42h | UTC

Management Of Adults And Children Undergoing CAR T-Cell Therapy: Best Practice Recommendations Of The European Society For Blood And Marrow Transplantation (EBMT) And The Joint Accreditation Committee Of ISCT And EBMT (JACIE) – Haematologica (free PDF)

 

Meta-Analysis: Early vs. Delayed Surgery After Short-course Radiotherapy for Rectal Cancer

24 Nov, 2019 | 20:41h | UTC

Early versus delayed surgery after short-course radiotherapy for rectal cancer: A network meta-analysis of randomized Controlled Trials – Asian Journal of Surgery (free)

 

Current Management of Barrett Esophagus and Esophageal Adenocarcinoma

18 Nov, 2019 | 00:24h | UTC

Current management of Barrett esophagus and esophageal adenocarcinoma – Cleveland Clinic Journal of Medicine (free)

Related: Review: Barrett Esophagus (free guidelines and review on the subject)

 

Meta-Analysis: Outcomes at Follow-up of Negative Colonoscopy in Average Risk Population

15 Nov, 2019 | 10:25h | UTC

Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis – The BMJ (free)

Related Guidelines: ACP Guideline: Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults (free) AND BMJ Guideline: Colorectal Cancer Screening with Fecal Immunochemical Testing, Sigmoidoscopy or Colonoscopy (new guideline suggesting a more selective approach to screening) AND Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society (recent guideline with recommendation to start screening at 45 years, with links to guidelines from other organizations)

“Our findings suggest that 10 year intervals for colonoscopy screening after a negative colonoscopy, as currently recommended, may be adequate”

 

[Abstract Only] Randomized Trial: Secondary Surgical Cytoreduction Not Beneficial for Recurrent Ovarian Cancer

14 Nov, 2019 | 10:34h | UTC

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Secondary surgery does not improve overall survival for recurrent ovarian cancer patients – University of Texas M. D. Anderson Cancer Center (free) AND Second surgery for many ovarian cancers found ineffective – Reuters (free)

 

Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation

14 Nov, 2019 | 10:32h | UTC

Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation – Clinical Infectious Diseases (free PDF)

 

ACR Consensus Guideline: O-RADS Risk Stratification and Management System for Ovarian-Adnexal Reporting

12 Nov, 2019 | 11:25h | UTC

O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee – Radiology (free)

 

Onco-Nephrology: Cancer, Chemotherapy and Kidney

12 Nov, 2019 | 11:15h | UTC

Onco-Nephrology: Cancer, chemotherapy and kidney – Nephrología (free)

Related: Onco-Nephrology: Core Curriculum – American Journal of Kidney Diseases (free) AND Onco-nephrology: an appraisal of the cancer and chronic kidney disease links – Nephrology Dialysis Transplantation (free) AND Opening an onconephrology clinic: recommendations and basic requirements – Nephrology Dialysis Transplantation (free) AND Onco-nephrology: current concepts and future perspectives – Japanese Journal of Clinical Oncology (free)

 

Guideline: Diagnosis, Therapy and Follow-up of Vaginal Cancer

12 Nov, 2019 | 10:53h | UTC

Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG – Geburtshilfe und Frauenheilkunde (free)

 

#ACR19 – [Not Published Yet] Cohort Study: Half of People with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors for Cancer Experience Flare, but Most Able to Continue Treatment

12 Nov, 2019 | 10:45h | UTC

Half of People with RA Treated with Immune Checkpoint Inhibitors for Cancer Experience Flare, but Most Able to Continue Treatment – American College of Rheumatology (free)

Abstract: Risk of Immunotherapy Related Toxicity in Patients with Rheumatoid Arthritis (free)

#ACR19 – Just Presented at the 2019 American College of Rheumatology Annual Meeting

 

[Abstract Only] Randomized Trial: Treatments for Relapsed or Refractory FLT3-mutated Acute Myeloid Leukemia Compared

10 Nov, 2019 | 12:57h | UTC

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: ADMIRAL: Gilteritinib vs Chemotherapy in Relapsed or Refractory FLT3-Mutated AML – The ASCO Post (free)

 

NCCN Guidelines: Gestational Trophoblastic Neoplasia

10 Nov, 2019 | 12:51h | UTC

Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology – Journal of National Comprehensive Cancer Network (free)

 

NCCN Guidelines Insights: Kidney Cancer

10 Nov, 2019 | 12:49h | UTC

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020 – Journal of National Comprehensive Cancer Network (free)

 

Viewpoint: Neuroendocrine Tumors—Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence

8 Nov, 2019 | 06:48h | UTC

Neuroendocrine Tumors—Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence – JAMA Oncology (free for a limited period)

 

Review: Dermatologic Conditions in Women Receiving Systemic Cancer Therapy

8 Nov, 2019 | 06:46h | UTC

Dermatologic conditions in women receiving systemic cancer therapy – International Journal of Women’s Dermatology (free)

 

ACP Guideline: Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults

5 Nov, 2019 | 10:43h | UTC

Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians – Annals of Internal Medicine (free)

News Release: ACP issues guidance for colorectal cancer screening – American College of Physicians (free)

Summaries for Patients: Colorectal Cancer Screening in Average-Risk Adults (free)

Commentaries: ACP issues new guidance on colorectal cancer screening – ACP Internist (free) AND Medical groups differ on when to start colon and rectal cancer screening. Here’s why – CNN (free)

Related: BMJ Guideline: Colorectal Cancer Screening with Fecal Immunochemical Testing, Sigmoidoscopy or Colonoscopy (new guideline suggesting a more selective approach to screening) AND Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society (recent guideline with recommendation to start screening at 45 years, with links to guidelines from other organizations)

 

Cohort Study: Incidence of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors

4 Nov, 2019 | 00:24h | UTC

The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors – Clinical Journal of the American Society of Nephrology (free for a limited period)

News Release: Study Examines Kidney Injury in Patients Taking Immunotherapy Cancer Medications – American Society of Nephrology (free)

Related: Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)

 

Related Commentary on Twitter

 

Perspective: The Oncology Care Model—Why It Works and Why It Could Work Better: Accounting for Novel Therapies in Value-Based Payment

3 Nov, 2019 | 19:56h | UTC

The Oncology Care Model—Why It Works and Why It Could Work Better: Accounting for Novel Therapies in Value-Based Payment – JAMA Oncology (free for a limited period)

 

Randomized Trial: Levofloxacin Prophylaxis Reduces Early Deaths in Patients with Newly Diagnosed Myeloma

30 Oct, 2019 | 08:17h | UTC

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial – The Lancet Oncology (free)

Commentaries: Reducing infection-related morbidity and mortality in patients with myeloma – The Lancet Oncology (free) AND Abx Prophylaxis Cuts Early Death in Newly Diagnosed Myeloma – MedPage Today (free)

 

Randomized Trial: Treatment vs. Observation in Smoldering Multiple Myeloma

30 Oct, 2019 | 08:15h | UTC

Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma – Journal of Clinical Oncology (free)

Commentary: Lenalidomide may delay onset of myeloma-related bone, organ damage – Mayo Clinic (free)

 

The Global Burden of Pancreatic Cancer

30 Oct, 2019 | 07:59h | UTC

The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 – The Lancet Gastroenterology & Hepatology (free)

Invited Commentary: Pancreatic cancer: a growing burden (free)

 

Related Commentary on Twitter

 

The Global Burden of Colorectal Cancer

30 Oct, 2019 | 07:55h | UTC

The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 – The Lancet Gastroenterology & Hepatology (free)

Invited Commentary: The global challenge of colorectal cancer (free)

 

Related Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.